Christopher M. Starr - 02 Dec 2025 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Reporting relationship
Director
Issuer ticker
MNPR
Reported as of
02 Dec 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Dec 2025, 16:50:08 UTC
Prior SEC filing
16 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Quan Vu, Attorney-in-fact

Key filing fact

Christopher M. Starr filed Form 4 for Monopar Therapeutics (MNPR) on 08 Dec 2025.

Key facts

  • This page summarizes Christopher M. Starr's Form 4 filing for Monopar Therapeutics (MNPR).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 08 Dec 2025, 16:50.

Change

  • Previous filing in this sequence was filed on 16 Jul 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001235470 Primary reporting owner

STARR CHRISTOPHER M

Relationship
Director
Address
1000 SKOKIE BLVD SUITE 350, WILMETTE
Signature
/s/ Quan Vu, Attorney-in-fact
Signature date
08 Dec 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MNPR transaction Derivative

Stock Options

Award

Transaction value
$0
Shares
+2,924
Change %
Price
$0.000000
Shares after
2,924
Date
02 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,924
Exercise price
$75.94
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options vest 25% quarterly on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .